Both in Pharmaceuticals
Rhythm Pharmaceuticals vs Kiniksa Pharmaceuticals International
Over the past year RYTM returned −24.0% and KNSA returned +149.0%; their daily moves had a correlation of 0.27.
RYTM −24.0% KNSA +149.0%Growth of $1, one year, split-adjusted
| Metric | RYTM | KNSA |
|---|---|---|
| Price | $86.44 | $93.29 |
| Market cap | $5.95B | $7.33B |
| Today | −7.49% | +2.74% |
| 1 month | −6.5% | +22.3% |
| 6 months | −6.4% | +64.4% |
| Year to date | −19.2% | +126.2% |
| 1 year | −24.0% | +152.1% |
| Revenue growth (YoY) | +46.9% | +58.1% |
| Gross margin | 87.5% | 90.3% |
| Net margin | −70.7% | 16.6% |
| P/E (TTM) | — | 66.9× |
| Price / sales | 24.8× | 7.7× |
| Net cash | $224.8M | $462.9M |
| Dividend yield | — | — |
| Volatility (60d) | 34.4% | 54.0% |
| Short % of float | 17.1% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).